Pembrolizumab in combination with ipilimumab as second-line or later therapy for advanced non–small-cell lung cancer: KEYNOTE-021 cohorts D and H
Titel:
Pembrolizumab in combination with ipilimumab as second-line or later therapy for advanced non–small-cell lung cancer: KEYNOTE-021 cohorts D and H
Auteur:
Gubens, Matthew A. Sequist, Lecia V. Stevenson, James P. Powell, Steven F. Villaruz, Liza C. Gadgeel, Shirish M. Langer, Corey J. Patnaik, Amita Borghaei, Hossein Jalal, Shadia I. Fiore, Joseph Saraf, Sanatan Raftopoulos, Harry Gandhi, Leena